Buscar resultados de ensayos clínicos
Carcinoma, Papillary - 33 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma Condición:
|
Withdrawn |
Nombre del estudio: Research Study in Patients With Advanced Ovarian Epithelial Cancer Condición:
|
Not yet recruiting |
Nombre del estudio: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Condición:
|
Recruiting |
Nombre del estudio: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condición:
|
Active, not recruiting |
Nombre del estudio: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer Condición:
|
Recruiting |
Nombre del estudio: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condición:
|
Not yet recruiting |
Nombre del estudio: Pembrolizumab and Lenvatinib in Treating Metastatic or Recurrent Differentiated Thyroid Cancer That Cannot Be Removed by Surgery Condición:
|
Recruiting |
Nombre del estudio: Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma Condición: Thyroid Papillary Carcinoma Fecha: 2015-12-13 Intervenciones:
|